Axsome
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1 World Trade Ctr Fl 29, New York, New Y...Phone Number
(212) 332-3241Website
www.axsome.comRevenue
$708.2 MillionStock Symbol
AXSMIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
2
2
1
1
1
About Axsome
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.Explore more
Axsome Org Chart
SO
Senior VP, Quality
MB
Vice President, Clinical Development
DC
Vice President, Clinical Development
RN
Vice President, Clinical & Regulatory
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axsome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Axsome
Click to see if Axsome had a recent Job posting/layoffs
Product Launch: Get notified when Axsome launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Axsome recently announced quarterly report
Funding: Get notified immidiatlly once Axsome has new funding data
Website visits: Recent activity has been detected on your website
Axsome, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Axsome has recently received funding, and reach out quickly before it becomes old news!
Check out if Axsome is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Axsome
Compare insights from companies similar to Axsome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$827.1M
501-1,000
Public
$2.5B
1998
QN
Quintus NgumahVice President, Clinical Development & Chief Marketing Officer, Cos To The
Company Profile Activity
Activity Insights
Axsome is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axsome is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axsome.
Axsome financials insights
Gather financial insights about Axsome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$3.7M
2014
Debt
$2M
Debt
$1.3M
2015
Debt
$2.5M
Stock Offering
$51M
2016
Debt
$20M
2025
Debt
$570M
Axsome Tech Stack
A closer look at the technologies used by Axsome
Most Recent Scoops
Open Position
Project
Axsome has announced the launch of AUVELITY in the Alzheimer's disease agitation indication, alongside the completion of an expanded AUVELITY sales force. Early metrics from the sales force expansion and the Alzheimer's disease agitation launch indicate growth acceleration for AUVELITY.
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Axsome
Sign Up For FreeTo access detailed company insights
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to develop... Read More
